Opinion

Video

Getting the Most From Your CLL Care Team

Author(s):

Yuliya P.L Linhares, MD,Josie Montegaard, MSN, AGPCNP-BC

Josie Montegaard, MSN, AGPCNP-BC, and Yuliya Linhares, MD, conclude their discussion with advice for patients with CLL on managing their diagnosis and treatment.

Video content above is prompted by the following question(s):

  • Do you have any advice for patients and their caregivers about how to work with their health care team to ensure best outcomes?
  • Why is it important for patients with chronic lymphocytic leukemia (CLL) to have a support network in place?
  • How and when should patients reach out to their health care team about treatment adverse effects or any changes in how they’re feeling?
  • Do you have any additional advice or key takeaways for patients as they manage their CLL diagnosis and treatment?
Related Videos
A panel of 3 experts on CML
Related Content
Illustration of red blood cells.
October 10th 2024

Jaypirca Plus Venclexta With or Without Rituxan May Be Beneficial in r/r CLL

Alex Biese
A phase 1b trial showed promising results among patients with relapsed or refractory chronic lymphocytic leukemia.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Illustration of a man with round glasses and a goatee.
October 7th 2024

My Bitter Chemotherapy Pills for Chronic Lymphocytic Leukemia

Chester Freeman
I’ve recently started on chemotherapy pills instead of infusions and the bitterness reminds me to accept not only the bitterness of the pill, but in life too.
CURE Talks Cancer podcast
December 31st 2020

The Treatment Journey of a Patient with CLL

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
Illustration of CLL cells.
September 17th 2024

Treatment Switching May Be Less Likely With Brukinsa vs Other BTK Inhibitors in CLL/SLL

Jax DiEugenio
Treatment with Brukinsa may lower the rates of switching therapies compared with Calquence and Imbruvica in chronic lymphocytic leukemia.
Illustration of chronic lymphocytic leukemia cells.
August 26th 2024

FDA Fast Tracks BGB-16673 for CLL, SLL

Brielle Benyon
The FDA granted a fast track designation to BGB-16673, a novel drug used to treat chronic lymphocytic leukemia and small lymphocytic lymphoma.